Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | 100.00% | -99.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 100.00% | -99.79% | |||
| Cost of Revenue | -- | -100.00% | |||
| Gross Profit | 0.00% | -99.73% | |||
| SG&A Expenses | 14.71% | 2.31% | |||
| Depreciation & Amortization | -46.77% | -21.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.06% | -16.70% | |||
| Operating Income | 1.24% | -27.77% | |||
| Income Before Tax | -5.08% | -9.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.08% | -9.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.08% | -9.94% | |||
| EBIT | 1.24% | -27.77% | |||
| EBITDA | 0.91% | -29.70% | |||
| EPS Basic | -3.70% | -12.50% | |||
| Normalized Basic EPS | -5.88% | -13.33% | |||
| EPS Diluted | -3.70% | -12.50% | |||
| Normalized Diluted EPS | -5.88% | -13.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
